HLD100

extended-release amphetamine · Ironshore Pharmaceuticals and Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLD100, covering 2014-10-03 to 2014-10-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 1, Phase 2]

See pricing